Assessment of CCL27 and IL-11 in Multiple Sclerosis Patients Treated with Interferon-β and Glatiramer Acetate 18 May 2020 | 09:59 Code : 9476 New Features Send To Others Your Name Your Email Recipient Email Send Cancel visits:19603 http://https://www.karger.com/Article/Abstract/505098
Your Comment :